Consumers Face Higher Costs for Everyday Essentials as Egg Prices Surge SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags TrumpRelated Stock Trades Spark Scrutiny Amid Transparency Concerns Mizuho Maintains Outperform Rating on ON Semiconductor Raises Price Target on AI Tailwinds Jim Cramer Highlights Opportunities Beyond AI in Monthly Portfolio Update Dating Startups Aim to Eliminate Fake Profiles A New Wave of Authenticity 36Kr Holdings KRKR Q1 2023 Earnings Net Loss Deepens as Revenue Visibility Remains Limited Texas Pacific Land Corporation TPL Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Steady Royalty Income BURL Q1 2026 Earnings EPS Beats Estimates Stock Rises 268 VZ Q1 2026 Earnings EPS Beats Estimates by 381 as Stock Eases Back on Mixed Signals ABVX Q4 2025 Earnings WiderThanExpected Loss Highlights ClinicalStage Biotech Challenges TECX Q1 2026 Earnings Loss Widens but Pipeline Optimism Drives Stock Higher Endeavour Silver EXK Slips 35 Key Support and Resistance Levels in Focus Alamo Group ALG Climbs 171 as Shares Approach Key Resistance Pan American Silver PAAS Drops 2 as Silver Weakness Weighs Key Support at 5152 in Focus Snail Inc SNAL Nears Support Level Amid Continued Selling Pressure Heartbeam Inc Warrants BEATW Rally 1077 as Price Hovers at Key Level Consumer Price Index Rises 38 YearoverYear in April Marking Fastest Pace Since May 2023 ORN Q1 2026 Earnings Earnings Beat Expectations with Surprise Profit Despite Unreported Revenue Magic Empire Global Limited MEGL Edges Higher Tests Key Resistance Near 120 BlackRock BLK Q1 2026 Earnings EPS Beat Drives Modest Stock Gain BY Q1 2026 Earnings EPS Beats Estimates by 755 Stock Slightly Down BIOA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage BHC Q1 2026 Earnings DoubleDigit EPS Surprise Lifts Sentiment PWR Q1 2026 Earnings Strong EPS Beat of 287 Lifts Investor Sentiment OPCH Q1 2026 Earnings EPS Beat Amid Caution Stock Slips 191 KZIA Q1 2026 Earnings EPS Misses Expectations Amid Clinical Progress Stock Rises